sirolimus is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., Usa. The primary component is Sirolimus.
Product ID | 68462-683_57fb4d90-3ccb-4a69-af1e-53be83f7a504 |
NDC | 68462-683 |
Product Type | Human Prescription Drug |
Proprietary Name | sirolimus |
Generic Name | Sirolimus |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2020-10-16 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA208691 |
Labeler Name | Glenmark Pharmaceuticals Inc., USA |
Substance Name | SIROLIMUS |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Decreased Immunologic Activity [PE],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-10-16 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0904-7147 | sirolimus | sirolimus |
0904-7248 | Sirolimus | Sirolimus |
13668-658 | Sirolimus | Sirolimus |
16714-187 | sirolimus | sirolimus |
16714-188 | sirolimus | sirolimus |
16714-189 | sirolimus | sirolimus |
68084-956 | Sirolimus | Sirolimus |
68084-915 | Sirolimus | Sirolimus |
68382-520 | sirolimus | sirolimus |
70954-075 | Sirolimus | Sirolimus |
50268-718 | Sirolimus | Sirolimus |
55111-654 | Sirolimus | Sirolimus |
55111-653 | Sirolimus | Sirolimus |
59762-1002 | Sirolimus | Sirolimus |
59762-1003 | Sirolimus | Sirolimus |
59762-1001 | Sirolimus | Sirolimus |
65841-771 | sirolimus | sirolimus |
66689-347 | Sirolimus | Sirolimus |
59762-1205 | Sirolimus | Sirolimus |
69238-1594 | Sirolimus | Sirolimus |
60505-6197 | Sirolimus | Sirolimus |
68462-682 | sirolimus | sirolimus |
68462-684 | sirolimus | sirolimus |
68462-683 | sirolimus | sirolimus |
0008-1030 | Rapamune | SIROLIMUS |
0008-1040 | Rapamune | SIROLIMUS |
0008-1041 | Rapamune | SIROLIMUS |
0008-1042 | Rapamune | SIROLIMUS |